Trials / Conditions / BRAF V600E-mutant Metastatic Colorectal Cancer
BRAF V600E-mutant Metastatic Colorectal Cancer
3 registered clinical trials studyying BRAF V600E-mutant Metastatic Colorectal Cancer — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | A Multi-omics Study of BRAF V600E Mutant Colorectal Cancer NCT07007689 | Sun Yat-sen University | — |
| Completed | Encorafenib, Binimetinib and Cetuximab in Subjects With Previously Untreated BRAF-mutant ColoRectal Cancer NCT03693170 | Pierre Fabre Medicament | Phase 2 |
| Completed | Study of Encorafenib + Cetuximab Plus or Minus Binimetinib vs. Irinotecan/Cetuximab or Infusional 5-Fluorourac NCT02928224 | Pfizer | Phase 3 |